- Home
- GCTK vs BDRX Comparison
GCTK vs BDRX Comparison
Compare GCTK & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTK
- BDRX
- Stock Information
- Founded
- GCTK 2001
- BDRX 2000
- Country
- GCTK United States
- BDRX United Kingdom
- Employees
- GCTK N/A
- BDRX N/A
- Industry
- GCTK Medical/Dental Instruments
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- GCTK Health Care
- BDRX Health Care
- Exchange
- GCTK Nasdaq
- BDRX Nasdaq
- Market Cap
- GCTK 3.3M
- BDRX 3.9M
- IPO Year
- GCTK N/A
- BDRX N/A
- Fundamental
- Price
- GCTK $7.15
- BDRX $6.75
- Analyst Decision
- GCTK
- BDRX
- Analyst Count
- GCTK 0
- BDRX 0
- Target Price
- GCTK N/A
- BDRX N/A
- AVG Volume (30 Days)
- GCTK 3.7M
- BDRX 48.5K
- Earning Date
- GCTK 11-13-2025
- BDRX 09-23-2025
- Dividend Yield
- GCTK N/A
- BDRX N/A
- EPS Growth
- GCTK N/A
- BDRX N/A
- EPS
- GCTK N/A
- BDRX N/A
- Revenue
- GCTK N/A
- BDRX N/A
- Revenue This Year
- GCTK N/A
- BDRX N/A
- Revenue Next Year
- GCTK N/A
- BDRX N/A
- P/E Ratio
- GCTK N/A
- BDRX N/A
- Revenue Growth
- GCTK N/A
- BDRX N/A
- 52 Week Low
- GCTK $4.22
- BDRX $5.00
- 52 Week High
- GCTK $2,928.00
- BDRX $108.90
- Technical
- Relative Strength Index (RSI)
- GCTK 56.95
- BDRX 53.33
- Support Level
- GCTK $6.18
- BDRX $6.31
- Resistance Level
- GCTK $6.66
- BDRX $7.00
- Average True Range (ATR)
- GCTK 0.59
- BDRX 0.40
- MACD
- GCTK 0.06
- BDRX 0.07
- Stochastic Oscillator
- GCTK 58.80
- BDRX 52.31
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.